Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles

ABOUT DATAMONITOR HEALTHCARE

• About the Cardiovascular pharmaceutical analysis team

EXECUTIVE SUMMARY

• Introduction
• Scope and coverage of the Brief
• Key findings

ATHEROSCLEROSIS OVERVIEW

• Disease definition
• Epidemiology
• Burden of atherosclerosis and coronary heart disease
• Mortality
• Cost

PREVENTION OF ATHEROSCLEROSIS

• Atherosclerotic risk factors
• Hypertension
• Hypercholesterolemia
• Overweight and obesity
• Diabetes
• Smoking
• AHA recommendations for the prevention of coronary heart disease
• Risk factor screening
• Global risk estimation
• Risk intervention
• Blood pressure control
• Blood lipid management
• Weight management
• Dietary intake
• Physical activity
• Smoking
• Aspirin
• Diabetes mellitus
• Therapeutic lifestyle changes
• Drug therapy
• Antihypertensives
• Statins
• Obesity drugs
• Antidiabetics
• Metabolic syndrome
• Metabolic syndrome definition
• Clinical criteria for diagnosis
• Metabolic syndrome and coronary heart disease

APPENDIX

• Bibliography
• Research methodology
• Disclaimer
• List of Tables
• Table 1: Epidemiology of cardiovascular disease, coronary heart disease and stroke in the US in 2002
• Table 2: Disability and mortality burdens of heart disease and stroke in the seven major markets in 2002
• Table 3: ATP III diagnostic criteria for metabolic syndrome
• Table 4: WHO working criteria for metabolic syndrome
• Table 5: IDF diagnostic criteria for metabolic syndrome